Kircik Leon H
Indiana University School of Medicine, Indianapolis, IN, USA.
J Drugs Dermatol. 2011 Jun;10(6):s17-23.
Topiucal drug therapy is an intuitively sound approach to the management of skin diseases. Depositing medication at the site of disease involvement is potentially effective and reduces systemic exposure. Topical drugs are absorbed usually by passive diffusion. In clinical practice, the choice of an optimized formulation that will be effective and well tolerated is essential. Data confirm that patient adherence with therapy leads to better outcomes and lower long-term treatment costs, while poor adherence is directly linked to poor treatment outcomes and and patient dissatisfaction. Local cutaneous irritation, which may be linked to components of the formulation and/or to the active drug itself, is a common cause of non-adherence. Well-designed drugs are important in the management of acne vulgaris and acne rosacea. Formulators have sought to improve treatment efficacy and tolerability by several different techniques, such as delayed release of the active drug, fixed combinations of two different molecules, or incorporating ingredients into the formulation vehicle that improve epidermal barrier function and offset the irritating effects of the active drugs.
局部药物治疗是皮肤病管理中一种直观合理的方法。将药物沉积在疾病累及部位可能有效,并减少全身暴露。局部药物通常通过被动扩散吸收。在临床实践中,选择一种有效且耐受性良好的优化制剂至关重要。数据证实,患者坚持治疗会带来更好的治疗效果和更低的长期治疗成本,而依从性差则直接与治疗效果不佳和患者不满相关。局部皮肤刺激可能与制剂成分和/或活性药物本身有关,是导致不依从的常见原因。精心设计的药物在寻常痤疮和玫瑰痤疮的管理中很重要。配方师试图通过几种不同技术提高治疗效果和耐受性,例如活性药物的延迟释放、两种不同分子的固定组合,或将改善表皮屏障功能并抵消活性药物刺激作用的成分纳入制剂载体中。